Safety of Stem-Cell Derived Therapies: Trends and Future Technologies 7/8 October 2019

By | Acellular / smart materials – 3D architecture, Engineered cell environment, Pluripotent stem cells and engineered cells

This important meeting, held at the John McIntyre Centre in Edinburgh on 7/8 October 2019, was brought to you by the UK Regenerative Medicine Platform (UKRMP) and the British Pharmacological Society.

Stem cell-derived therapies are complex and diverse, so it is critical that we understand the challenges faced in getting clinical trials for these therapies approved.

Across two days, we discussed how some therapies have made progress towards clinical trials, particularly in relation to assessing safety. We also looked at areas where new technologies can fill vital gaps, such as in combination therapies with smart materials.

The meeting was attended pharmacologists, working in toxicology, clinicians, academics and industry. Regulators, including MHRA and FDA, also joined our panel discussions.

Delegates were able to hear from leaders in the field including Pete Coffey, Agnete Kirkeby, Martin Pera, Kevin Eggan and our key note speaker, Jane Lebkowski.

Find out more 

UKRMP-funded Virtual Tour opens its doors.

By | Engineered cell environment

Users are able to tour around the MRC Centre for Regenerative Medicine at the University of Edinburgh. Your guide is Sophie Quick, who is a PhD student at the Centre.

Use the following link to access the tour: 

The tour is a great tool for public engagement and outreach activities. Users can travel throughout the MRC CRM building and find out what it is like to be a researcher within this research centre. A great tool for all members of the UKRMP network.